30 Days and 90 Days Heart Failure Re-Admission at Komfo Anokye Teaching Hospital | MicrobiomeTrials← Back to trialsNCT07100561
30 Days and 90 Days Heart Failure Re-Admission at Komfo Anokye Teaching Hospital
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2025-07-14Est. Completion: 2027-12-31
Enrollment target: 220 participants Locations- Komfo Anokye Teaching Hospital, Kumasi, Ashanti Region, Ghana
Other microbiome trials you might be interested in
Systemic SclerosisScleroderma
The purpose of this study is to evaluate the efficacy and safety of treatment with subcutaneous anifrolumab versus place…
Scottsdale, United StatesEst. completion Jan 6, 2027
Heart Failure
Combination therapy of finerenone plus empagliflozin will be compared to usual care to determine the efficacy and safety…
Fairhope, United StatesEst. completion Nov 2027
Recruiting
To assess the long-term safety and efficacy of the BAROSTIM NEO System in trial (NCT01471834) participants.
Calgary, CanadaEst. completion May 2012